Skip to main content

Morgan Stanley Sticks to Its Buy Rating for Metlife (MET)

Tipranks - Tipranks - Wed Mar 4, 7:34AM CST

Morgan Stanley analyst Bob Huang maintained a Buy rating on Metlife today and set a price target of $93.00.

Claim 70% Off TipRanks Premium

Huang covers the Financial sector, focusing on stocks such as Progressive, Voya Financial, and Prudential Financial. According to TipRanks, Huang has an average return of -5.0% and a 46.90% success rate on recommended stocks.

In addition to Morgan Stanley, Metlife also received a Buy from TipRanks – Google’s Google Insurance – Life in a report issued on February 27. However, on the same day, TipRanks – Anthropic reiterated a Hold rating on Metlife (NYSE: MET).

See the top stocks recommended by analysts >>

Based on Metlife’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $23.81 billion and a net profit of $809 million. In comparison, last year the company earned a revenue of $18.44 billion and had a net profit of $1.27 billion

Read More on MET:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).